{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:47:38Z","timestamp":1789001258434,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T00:00:00Z","timestamp":1651708800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.ebiom.2022.104068","type":"journal-article","created":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T18:00:54Z","timestamp":1653156054000},"page":"104068","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["The relationship between disease activity and UDCA response criteria in primary biliary cholangitis: A cohort study"],"prefix":"10.1016","volume":"80","author":[{"given":"David E.J.","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4989-9726","authenticated-orcid":false,"given":"Aaron","family":"Wetten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Barron-Millar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Ogle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Mells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Flack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Sandford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Kirby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Brotherston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Jopson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Brain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham R.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Rushton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9087-6836","authenticated-orcid":false,"given":"Rebecca","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Rushbrook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Thorburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D.","family":"Ryder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gideon","family":"Hirschfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica K.","family":"Dyson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ebiom.2022.104068_bib0001","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"EASL Clinical Practice Guidelines: the diagnosis and management of patients with primary biliary cholangitis","volume":"67","author":"Hirschfield","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.ebiom.2022.104068_bib0002","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1136\/gutjnl-2017-315259","article-title":"The British Society of Gastroenterology\/UK-PBC primary biliary cholangitis treatment and management guidelines","volume":"67","author":"Hirschfield","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.ebiom.2022.104068_bib0003","article-title":"Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases","author":"Lindor","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.ebiom.2022.104068_bib0004","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1053\/j.gastro.2014.08.029","article-title":"Levels of alkaline phosphatase and bilirubin are surrogate endpoints of outcomes of patients with primary biliary cirrhosis - an international follow-up study","volume":"147","author":"Lammers","year":"2014","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104068_bib0005","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1053\/j.gastro.2012.12.005","article-title":"Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid","volume":"144","author":"Carbone","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ebiom.2022.104068_bib0006","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/hep.28128","article-title":"Risk stratification in autoimmune cholestatic liver diseases: opportunities for clinicians and trialists","volume":"63","author":"Trivedi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.ebiom.2022.104068_bib0007","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1007\/s10620-018-5074-8","article-title":"Are clinicians ready for safe use of stratified therapy in primary biliary cholangitis (PBC)? A study of educational awareness","volume":"63","author":"Jopson","year":"2018","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ebiom.2022.104068_bib0008","article-title":"Patient ownership of primary biliary cholangitis long term management","author":"Leighton","year":"2020","journal-title":"Frontline Gastro"},{"key":"10.1016\/j.ebiom.2022.104068_bib0009","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.14309\/ajg.0000000000000557","article-title":"Goals of treatment for improved survival in primary biliary cholangitis: treatment target should be bilirubin within the normal range and normalization of alkaline phosphatase","volume":"115","author":"Murillo Perez","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ebiom.2022.104068_bib0010","doi-asserted-by":"crossref","DOI":"10.1002\/hep.32011","article-title":"The serum proteome and ursodeoxycholic acid response in primary biliary cholangitis","author":"Barron-Millar","year":"2021","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104068_bib0011","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/ng.789","article-title":"Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis","volume":"43","author":"Mells","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.ebiom.2022.104068_bib0012","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1053\/j.gastro.2012.12.005","article-title":"Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid","volume":"144","author":"Carbone","year":"2013","journal-title":"Gastorenterology"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104068_bib0013","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jhep.2013.02.019","article-title":"The impact of liver transplantation on the phenotype of primary biliary cirrhosis patients in the UK-PBC cohort","volume":"59","author":"Pells","year":"2013","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104068_bib0014","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/hep.26365","article-title":"Impact of primary biliary cirrhosis on perceived quality of life: the UK-PBC national study","volume":"58","author":"Mells","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.ebiom.2022.104068_bib0015","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/hep.28017","article-title":"The UK-PBC risk scores: derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cirrhosis","volume":"60","author":"Carbone","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.ebiom.2022.104068_bib0016","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1111\/apt.13794","article-title":"The inter-relationship of symptom severity and quality of life in 2055 patients with primary biliary cholangitis","volume":"44","author":"Dyson","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ebiom.2022.104068_bib0017","first-page":"626","article-title":"Early patient stratification to enable personalized management of patients with primary biliary cholangitis","volume":"3","author":"Carbone","year":"2018","journal-title":"Lancet Gastro Hep"},{"key":"10.1016\/j.ebiom.2022.104068_bib0018","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jaut.2018.07.020","article-title":"Increased sensitivity of Treg cells from patients with PBC to low dose IL-12 drives their differentiation into IFN-\u03b3 secreting cells","volume":"94","author":"Liaskou","year":"2018","journal-title":"J Autoimmun"},{"key":"10.1016\/j.ebiom.2022.104068_bib0019","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/hep.22428","article-title":"Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis","volume":"48","author":"Corpechot","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.ebiom.2022.104068_bib0020","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa1509840","article-title":"A placebo-controlled trial of obeticholic acid in primary biliary cholangitis","volume":"373","author":"Nevens","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2022.104068_bib0021","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.jhep.2011.02.031","article-title":"Early primary biliary cirrhosis: biochemical response to treatment and prediction of long-term outcome","volume":"55","author":"Corpechot","year":"2011","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104068_bib0022","doi-asserted-by":"crossref","first-page":"e95192","DOI":"10.1371\/journal.pone.0095192","article-title":"Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability","volume":"9","author":"Assarsson","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ebiom.2022.104068_bib0023","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S2468-1253(18)30043-8","article-title":"Unmet needs and new models for future trials in autoimmune hepatitis","volume":"3","author":"Jones","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.ebiom.2022.104068_bib0024","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1586\/1744666X.2016.1147956","article-title":"Chemokine and chemokine receptors in autoimmunity: the case of primary biliary cholangitis","volume":"12","author":"Choi","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104068_bib0025","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1053\/j.gastro.2014.06.043","article-title":"Roles for chemokines in liver disease","volume":"147","author":"Marra","year":"2014","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.ebiom.2022.104068_bib0026","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/j.1478-3231.2011.02504.x","article-title":"Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases","volume":"31","author":"Tacke","year":"2011","journal-title":"Liver International"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104068_bib0027","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1146\/annurev.immunol.19.1.423","article-title":"Interleukin-18 regulates both Th1 and Th2 responses","volume":"19","author":"Nakanishi","year":"2001","journal-title":"Annu Rev Immunol"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104068_bib0028","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.jhep.2016.02.003","article-title":"Lights on MAIT cells, a new immune player in liver diseases","volume":"64","author":"Toubal","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.ebiom.2022.104068_bib0029","doi-asserted-by":"crossref","first-page":"8019","DOI":"10.1038\/ncomms9019","article-title":"International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways","volume":"6","author":"Cordell","year":"2015","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.ebiom.2022.104068_bib0030","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1136\/gut.2004.062398","article-title":"Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2","volume":"54","author":"Paizis","year":"2005","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104068_bib0031","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jhep.2007.03.008","article-title":"Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1\u20137) levels in experimental biliary fibrosis","volume":"47","author":"Herath","year":"2007","journal-title":"J Hepatol"},{"issue":"8104","key":"10.1016\/j.ebiom.2022.104068_bib0032","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/S0140-6736(78)91972-4","article-title":"Serum angiotensin-converting enzyme (Sace) in sarcoidosis and other granulomatous disorders","volume":"312","author":"Studdy","year":"1978","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ebiom.2022.104068_bib0033","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1111\/liv.14466","article-title":"Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitis","volume":"40","author":"Bossen","year":"2020","journal-title":"Liver International"},{"key":"10.1016\/j.ebiom.2022.104068_bib0034","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/hep4.1170","article-title":"NI-0801, an anti-CXCL10 antibody, in patients with primary biliary cholangitis and an incomplete response to ursodeoxycholic acid","volume":"2","author":"de Graaf","year":"2018","journal-title":"Hepatol Comm"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104068_bib0035","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0210-5705(03)79085-2","article-title":"Pons Romero F. Plasma leptin levels in patients with primary biliary cirrhosis and their relationship with degree of fibrosis","volume":"27","author":"Garc\u00eda-Su\u00e1rez","year":"2004","journal-title":"Gastroenterolog\u00eda y Hepatolog\u00eda"},{"issue":"9","key":"10.1016\/j.ebiom.2022.104068_bib0036","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/00042737-200509000-00007","article-title":"Serum leptin, soluble leptin receptor, free leptin index and bone mineral density in patients with primary biliary cirrhosis","volume":"17","author":"Szalay","year":"2005","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104068_bib0037","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/gut.51.3.434","article-title":"Fatigue is associated with high circulating leptin levels in chronic hepatitis C","volume":"51","author":"Piche","year":"2002","journal-title":"Gut"},{"issue":"Suppl 2","key":"10.1016\/j.ebiom.2022.104068_bib0038","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000440757","article-title":"Fatigue in primary biliary cirrhosis: prevalence, pathogenesis and management","volume":"33","author":"Jopson","year":"2015","journal-title":"Dig Dis"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396422002493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396422002493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:15:06Z","timestamp":1762456506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396422002493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":38,"alternative-id":["S2352396422002493"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2022.104068","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The relationship between disease activity and UDCA response criteria in primary biliary cholangitis: A cohort study","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2022.104068","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104068"}}